
While technology is already impacting the pharma industry, automation and the Internet of things (IoT) will intensify over the next two years, and those companies that experiment and embrace it will have a “dramatic and competitive advantage.”

While technology is already impacting the pharma industry, automation and the Internet of things (IoT) will intensify over the next two years, and those companies that experiment and embrace it will have a “dramatic and competitive advantage.”

Pharma must develop digital identity strategies for creating seamless, safe and compliant customer journeys, writes Jamie Beckland.

If pharma companies want to hold their own in the current climate, they must embrace rather than resist market change, writes Peter Muller.


While it is foundational to commercial operations, most European life sciences companies are not getting what they need from their customer data, writes Guillame Roussel.

With big data one of the hot healthcare topics of the moment, we gauge pharma’s response to the hype to see if the industry is poised to take advantage of the promise of advanced analytics.

Jeff R. Livingstone outlines the critical steps necessary to ensure an agile, responsive and streamlined supply chain.

Amid the push for a more intelligent and predictive supply chain, is it imperative for pharma companies to advance with their supply chain digitization strategies now-or is there still time to “wait and see?”

Pharmaceutical Executive
How integrating next-generation sequencing data can advance efforts in immuno-oncology research.

Laurent Fanichet outlines four ways pharma companies can use cognitive search and search-based applications to improve competitiveness.

Stan Bernard outlines the seven ways for pharmas to ensure successful execution of action steps following brand ‘war games’.

Stakeholders around the world can benefit from RWD as it can improve patient outcomes and speed at which products come to market.

February 15, 2017

February 09, 2017

Pharmaceutical Executive
February 06, 2017

The populist-driven shifts trumpeted from the US to the EU leaves plenty of question marks when trying to size up the trajectory of the global pharma industry. One certainty, however, will be change.

February 03, 2017



January 25, 2017


January 23, 2017

January 19, 2017

January 16, 2017

January 11, 2017